A CANCER RESEARCH UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford. The trial, led by a team based at the National Institute for ... READ MORE
News for Cancer
Small molecules found to play complex role in cancer metastasis
While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another. A team of researchers from The Cancer Institute of New Jersey (CINJ) and Princeton ... READ MORE
Rare tumour’s ‘fingerprint’ used to develop cheap and reliable new test
Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique to this cancer. Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a disorder ... READ MORE
ARCII-study in Oxford – the human face of medical breakthrough
Last December, Kevin Jones, a 43-year-old businessman from Dorset was diagnosed with pancreatic cancer. It was advanced and inoperable. Today, as he prepares to celebrate Christmas with his son, Mr Jones is free from any detectable trace of the disease; the human face of a medical breakthrough so ... READ MORE
An aspirin a day helps to keep cancer at bay
Taking a low-dose aspirin every day will reduce your chances of dying from cancer, scientists say today, confirming the over-the-counter pill as the most extraordinary drug yet discovered. Daily aspirin has already been shown to cut the chances of heart attacks and stroke in people who are at ... READ MORE
Aspirin ‘can significantly reduce’ bowel cancer risk
Professor Peter Rothwell, of the John Radcliffe Hospital, Oxford, and Oxford University, describes the findings of a recent study, tipping the balance in favour of regular aspirin ... READ MORE
Clinical trials begin of new treatment for advanced Melanoma in the UK & USA
Researchers at Immunocore Limited today announced that IMCgp100, a targeted therapeutic for the treatment of advanced metastatic melanoma, has received regulatory and ethics approval and has opened enrolment for clinical trials in the England and USA. IMCgp100 is the first clinical candidate ... READ MORE
Tumour mapping for novel cancer treatment in Oxford
Professor Mark Middleton, Professor John Bell, Dr Jenny Taylor and research colleagues from Oxford were interviewed on BBC Radio 4 on 17 February about new generations of cancer drugs. Discussions centred around advances in tumour mapping, patients' experiences, advances in genetic testing and ... READ MORE